The importance of using strict inclusion criteria in subclinical hypothyroid studies [1]

American Journal of Medicine

Volumn 114, Issue 1, 2003, Pages 76-

  Biondi, Bernadette ^a   Palmieri, Emiliano A ^a   Lombardi, Gaetano ^a   Fazio, Serafino ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; THYROID ANTIBODY; THYROTROPIN; THYROXINE;

ANTIBODY DETECTION; ANXIETY; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE DURATION; DRUG INDICATION; DRUG RESPONSE; HORMONE DETERMINATION; HUMAN; HYPOTHYROIDISM; LETTER; PATIENT SELECTION; PRIORITY JOURNAL; SCREENING; THYROID DISEASE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL;

FEMALE; HUMANS; HYPOTHYROIDISM; PATIENT SELECTION; THYROTROPIN; THYROXINE; TREATMENT OUTCOME;

EID: 0037248835     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(02)01260-3     Document Type: Letter

References (6)

1. Cooper D.S., Halpern R., Wood L.C., et al. L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med. 101:1984;18-24.
2. Meier C., Staub J.J., Roth C.B., et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism a double-blind, placebo-controlled trial (Basel Thyroid Study) . J Clin Endocrinol Metab. 86:2001;4860-4866.
3. Caraccio C., Ferrannini E., Monzani F. Lipoprotein profile in subclinical hypothyroidism response to levothyroxine replacement, a randomised placebo-controlled study . J Clin Endocrinol Metab. 87:2002;1533-1538.
4. Kong W.M., Sheikh M., Lumb P.J., et al. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am J Med. 112:2002;348-354.
5. McDermott M.T., Ridgway E.C. Subclinical hypothyroidism is mild failure and should be treated. J Clin Endocrinol Metab. 86:2001;4585-4590.
6. Chu J.W., Crapo L.M. The treatment of subclinical hypothyroidism is seldom necessary. J Clin Endocrinol Metab. 86:2001;4591-4599.